Pfizer’s Ngenla finally secures FDA approval following a rocky road to market
Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paediatric growth hormone deficiency treatment.
Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paediatric growth hormone deficiency treatment.
What's Your Reaction?
